New patent for Apellis Pharms drug SYFOVRE

Annual Drug Patent Expirations for SYFOVRE Syfovre is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are ten patents…

Source


Comments are closed.

Biotechblog